Natdac is a prescription medicine used to treat chronic (lasting a long time) hepatitis C genotype 1 or genotype 3 infection in adults.Active Ingredients: Daclatasvir
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Natdac (daclatasvir) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Natdac (daclatasvir) tablets medicine cost price in India.
The order for Natdac (daclatasvir) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Daclatasvir is used in combination with Sofosbuvir 400mg tablet for treatment of patients with chronic HCV genotype 3 infection. Offer shortest treatment duration irrespective of all genotypes. Offering high tolerability and safe usage. Offering superior efficacy in Hepatitis C Genotype 3.
Daclatasvir, sold under the trade name Daklinza, is a medication used in combination with other medications to treat hepatitis C (HCV). The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis.
Natdac (daclatasvir) tablets
Generic Name: daclatasvir
Tablets: 60 mg, 30 mg, and 90 mg
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Natdac (daclatasvir) tablets on prescription and Import License in Patient's Name only.
For overseas patients, Natdac (daclatasvir) tablets can be made available in Send your enquiry to find Natdac (daclatasvir) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.